TVM Capital
Finance · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Ottostr. 4, Munich, Bavaria, 80333, Germ...Phone Number
+49 899989920Website
www.tvm-capital.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About TVM Capital
TVM Capital Life Science is a transatlantic venture capital firm focused on investing in innovative life science products and companies. They provide capital and expertise to support the development of breakthrough therapies and medical products that aim to transform healthcare. Their unique strategy includes financing early-stage therapeutics and investing in differentiated commercial-stage medtech, diagnostics, and digital health products. With a strong team and a commitment to partnership, they strive to enable portfolio companies to bring new therapies to market.Explore more
TVM Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TVM Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
TVM Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at TVM Capital
Product Launch: Get notified when TVM Capital launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if TVM Capital had a recent Job posting/layoffs
Earning: See what the market has to say on TVM Capital recently announced quarterly report
Funding: Get notified immidiatlly once TVM Capital has new funding data
Website visits: Recent activity has been detected on your website
Check if TVM Capital has recently received funding, and reach out quickly before it becomes old news!
Check out if TVM Capital is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
TVM Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
TVM Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about TVM Capital.
TVM Capital Tech Stack
A closer look at the technologies used by TVM Capital
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
TVM Capital News & Media
AL-S Pharma Appoints Internationally Recognized Neurologist and Clinical Trial Expert Prof. Dr. Angela Genge as Chief Medical Officer
ZURICH, Sept. 25, 2025 /PRNewswire/ -- AL-S Pharma announced today that it has appointed Angela Genge, MD, Professor of Neurology at McGill University in Montreal, as Chief Medical Officer (CMO). With a distinguished record in amyotrophic lateral sclerosis (ALS) research and the Head of...AL-S Pharma announces positive topline results from Phase 2 study of AP-101 for the treatment of amyotrophic lateral sclerosis (ALS)
Phase 2 of AP-101 in sporadic ALS and mutant SOD1-ALS met its primary safety and tolerability endpoint Clinically meaningful changes in outcome measures and stabilization of biomarkers were observed Data will be presented at upcoming scientific conferences and AL-S Pharma plans to engage...TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology Pioneer, Smart Reporting
MUNICH, Germany and MONTREAL, April 22, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today announced the successful closing of a €23 million Series C financing round for Smart Reporting, a pioneer and market leader in the field of medical reporting, particularly in radiology and pathology. TVM led the round, supported by Bayern Kapital and existing investors. The proceeds will beMyosotis Raises €8M in Series A Funding
Myosotis (“myo”), a Berlin, Germany-based digital healthcare startup, raised €8M in Series A funding. The round saw participation from TVM Capital with participation from Twip. Existing shareholders included nursing home operators Agaplesion and Carpe Diem, as well as the venture capital funds BonVenture, Axel Springer Plug & Play, Think Health, Mountain Partners, Round Hill Ventures […] The post Myosotis Raises €8M in Series A Funding appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TVM Capital
Sign Up For FreeTo access detailed company insights
TVM Capital Life Science is a transatlantic venture capital firm focused on investing in innovative life science products and companies. They provide capital and expertise to support the development of breakthrough therapies and medical products that aim to transform healthcare. Their unique strategy includes financing early-stage therapeutics and... Read More
